The Raymond James Trust N.A. Buys 4,379 Shares of MetLife, Inc. (MET)

The Raymond James Trust N.A. Buys 4,379 Shares of MetLife, Inc. (MET)

Raymond James Trust N.A. lifted its stake in shares of MetLife, Inc. (NYSE:MET) by 6.8% during the third quarter, according to its most recent disclosure with the Securities and Exchange Commission. The firm owned 68,335 shares of the financial services provider’s stock after acquiring an additional 4,379 shares during the quarter. Raymond James Trust N.A.’s holdings in MetLife were worth $3,551,000 as of its most recent filing with the Securities and Exchange Commission.

Several other institutional investors also recently bought and sold shares of the company. Bronfman E.L. Rothschild L.P. increased its position in shares of MetLife by 0.7% during the second quarter. Bronfman E.L. Rothschild L.P. now owns 5,505 shares of the financial services provider’s stock worth $302,000 after acquiring an additional 38 shares during the period. Forward Management LLC increased its position in shares of MetLife by 0.4% during the second quarter. Forward Management LLC now owns 9,661 shares of the financial services provider’s stock worth $531,000 after acquiring an additional 41 shares during the period. Aspen Investment Management Inc increased its position in shares of MetLife by 0.7% during the second quarter. Aspen Investment Management Inc now owns 7,178 shares of the financial services provider’s stock worth $394,000 after acquiring an additional 50 shares during the period. Atria Investments LLC increased its position in shares of MetLife by 0.4% during the second quarter. Atria Investments LLC now owns 18,986 shares of the financial services provider’s stock worth $1,043,000 after acquiring an additional 72 shares during the period. Finally, Apriem Advisors increased its position in shares of MetLife by 0.6% during the second quarter. Apriem Advisors now owns 13,060 shares of the financial services provider’s stock worth $718,000 after acquiring an additional 74 shares during the period. 74.25% of the stock is currently owned by institutional investors and hedge funds.

MetLife, Inc. (NYSE:MET) traded up 0.380% during trading on Thursday, reaching $54.145. 1,413,199 shares of the company’s stock traded hands. The stock has a 50-day moving average price of $51.21 and a 200 day moving average price of $48.27. The stock has a market capitalization of $57.55 billion, a P/E ratio of 637.000 and a beta of 1.47. MetLife, Inc. has a 1-year low of $40.53 and a 1-year high of $54.35.

MetLife (NYSE:MET) last released its earnings results on Wednesday, August 2nd. The financial services provider reported $1.30 earnings per share for the quarter, topping the Thomson Reuters’ consensus estimate of $1.28 by $0.02. The company had revenue of $17.39 billion during the quarter, compared to the consensus estimate of $17.11 billion. MetLife had a net margin of 0.30% and a return on equity of 8.51%. The company’s revenue was up 2.5% on a year-over-year basis. During the same quarter in the previous year, the firm earned $0.83 EPS. Equities research analysts expect that MetLife, Inc. will post $4.77 earnings per share for the current year.

The business also recently announced a quarterly dividend, which will be paid on Wednesday, December 13th. Stockholders of record on Monday, November 6th will be given a $0.40 dividend. This represents a $1.60 annualized dividend and a dividend yield of 2.97%. The ex-dividend date of this dividend is Friday, November 3rd. MetLife’s payout ratio is currently 1,777.98%.

A number of research firms have recently weighed in on MET. Wells Fargo & Company reaffirmed a “buy” rating on shares of MetLife in a research report on Wednesday, October 18th. Goldman Sachs Group, Inc. (The) initiated coverage on shares of MetLife in a research note on Wednesday, October 18th. They set a “conviction-buy” rating and a $61.00 target price for the company. FBR & Co downgraded shares of MetLife from a “buy” rating to a “neutral” rating and lowered their target price for the stock from $53.00 to $52.00 in a research note on Tuesday, October 10th. ValuEngine downgraded shares of MetLife from a “strong-buy” rating to a “buy” rating in a research note on Tuesday, October 10th. Finally, Zacks Investment Research upgraded shares of MetLife from a “strong sell” rating to a “hold” rating in a research note on Monday, October 9th. One analyst has rated the stock with a sell rating, nine have given a hold rating, nine have given a buy rating and one has issued a strong buy rating to the company. The company currently has an average rating of “Buy” and an average target price of $57.62.

MetLife Profile

MetLife, Inc is a provider of life insurance, annuities, employee benefits and asset management. The Company’s segments include U.S.; Asia; Latin America; Europe, the Middle East and Africa (EMEA); MetLife Holdings, and Corporate & Other. Its U.S. segment is organized into Group Benefits, Retirement and Income Solutions and Property & Casualty businesses.

Want to see what other hedge funds are holding MET? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for MetLife, Inc. (NYSE:MET).

Related posts

Leave a Comment